Tj Biopharma Co., Ltd.
Clinical trials sponsored by Tj Biopharma Co., Ltd., explained in plain language.
-
New hope for rare immune storm: experimental drug targets severe MAS
Disease control Recruiting nowThis study tests an experimental drug called plonmarlimab in 30 people aged 16 to 80 who have a rheumatic disease and a severe immune overreaction known as MAS that has not responded to prior treatments. The goal is to see if the drug can control the overactive immune system and …
Phase: PHASE3 • Sponsor: TJ Biopharma Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 02:19 UTC
-
New gout drug aims to stop flare pain in 72 hours
Symptom relief Recruiting nowThis study tests an experimental drug, punarlimab, for people with acute gouty arthritis. About 170 adults who have had at least three gout flares in the past year will receive either the new drug or an active comparator. The main goal is to see if punarlimab reduces pain within …
Phase: PHASE2 • Sponsor: TJ Biopharma Co., Ltd. • Aim: Symptom relief
Last updated May 08, 2026 12:03 UTC
-
Healthy men needed to compare two forms of TJ101 injection
Knowledge-focused Recruiting nowThis study tests whether a new version of TJ101 injection works the same as the current one in healthy adult men. Participants get a single shot of each version at different times, and researchers measure drug levels in their blood. The goal is to confirm the two formulations are…
Phase: PHASE1 • Sponsor: TJ Biopharma Co., Ltd. • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC